Spero Therapeutics, Inc.
SPRO
$1.87
$0.010.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.19M | 48.89M | 52.89M | 76.29M | 63.53M |
| Total Receivables | 26.91M | 24.28M | 52.48M | 53.28M | 55.50M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.30M | 1.55M | 1.91M | 2.06M | 3.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 59.40M | 74.71M | 107.28M | 131.63M | 122.22M |
|
|
|||||
| Total Current Assets | 59.40M | 74.71M | 107.28M | 131.63M | 122.22M |
| Net Property, Plant & Equipment | 2.56M | 2.84M | 3.11M | 3.38M | 3.64M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 153.00K | 153.00K | 153.00K | 153.00K | 24.02M |
| Total Assets | 62.12M | 77.71M | 110.54M | 135.16M | 149.88M |
|
|
|||||
| Total Accounts Payable | 780.00K | 1.77M | 7.31M | 6.09M | 2.70M |
| Total Accrued Expenses | 6.64M | 8.05M | 34.99M | 15.33M | 10.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.84M | 1.80M | 1.75M | 1.74M | 1.73M |
| Total Finance Division Other Current Liabilities | 5.68M | 17.55M | 45.05M | 25.94M | 31.19M |
| Total Other Current Liabilities | 5.68M | 17.55M | 45.05M | 25.94M | 31.19M |
| Total Current Liabilities | 14.95M | 29.16M | 49.07M | 49.10M | 45.63M |
|
|
|||||
| Total Current Liabilities | 14.95M | 29.16M | 49.07M | 49.10M | 45.63M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.77M | 2.17M | 2.55M | 2.88M | 3.21M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.58M | 12.58M | 12.80M | 17.68M | 20.54M |
| Total Liabilities | 29.29M | 43.90M | 64.42M | 69.65M | 69.38M |
|
|
|||||
| Common Stock & APIC | 508.03M | 507.32M | 505.76M | 504.26M | 502.10M |
| Retained Earnings | -475.20M | -473.50M | -459.64M | -438.75M | -421.60M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 32.83M | 33.81M | 46.12M | 65.51M | 80.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.83M | 33.81M | 46.12M | 65.51M | 80.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.83M | 33.81M | 46.12M | 65.51M | 80.50M |
|
|
|||||